Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pasadena, CA
SEC filing record 1 source field available
Fiscal year end
30 September
ARROWHEAD PHARMACEUTICALS, INC. has filed 1,338 SEC EDGAR filings since 02 Jan 1998

SEC filing history

Showing 276-300 of 995 matching filings.

Per page
25
Current page
12
DEF 14A File 001-38042

DEF 14A

Filing date
30 Jan 2023
Reporting date
30 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48710

SC 13G/A filing

Filing date
26 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38042

PRE 14A

Filing date
20 Jan 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48710

SC 13G filing

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jan 2023
Reporting date
10 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2023
Reporting date
05 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jan 2023
Reporting date
05 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2023
Reporting date
04 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2023
Reporting date
04 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2023
Reporting date
04 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jan 2023
Reporting date
03 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Dec 2022
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Dec 2022
Reporting date
21 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-268665

S-3ASR

Filing date
05 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .